Capstone Investment Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.24M | Buy |
49,800
+22,900
| +85% | +$2.04M | 0.01% | 456 |
|
|
2025
Q4 | $2.13M | Sell |
26,900
-21,500
| -44% | -$1.69M | ﹤0.01% | 601 |
|
|
2025
Q3 | $3.87M | Buy |
48,400
+19,000
| +65% | +$1.62M | 0.01% | 548 |
|
|
2025
Q2 | $2.67M | Sell |
29,400
-59,800
| -67% | -$5.46M | 0.01% | 552 |
|
|
2025
Q1 | $8.36M | Sell |
89,200
-30,600
| -26% | -$2.74M | 0.02% | 344 |
|
|
2024
Q4 | $10.9M | Buy |
119,800
+39,300
| +49% | +$3.75M | 0.03% | 340 |
|
|
2024
Q3 | $8.36M | Sell |
80,500
-6,700
| -8% | -$683K | 0.03% | 340 |
|
|
2024
Q2 | $8.46M | Buy |
87,200
+18,700
| +27% | +$1.73M | 0.03% | 339 |
|
|
2024
Q1 | $6.17M | Sell |
68,500
-35,400
| -34% | -$3M | 0.02% | 378 |
|
|
2023
Q4 | $8.28M | Buy |
103,900
+43,800
| +73% | +$3.29M | 0.02% | 385 |
|
|
2023
Q3 | $4.27M | Buy |
60,100
+8,900
| +17% | +$665K | 0.02% | 474 |
|
|
2023
Q2 | $3.94M | Buy |
51,200
+5,300
| +12% | +$410K | 0.02% | 444 |
|
|
2023
Q1 | $3.45M | Sell |
45,900
-84,800
| -65% | -$6.31M | 0.02% | 449 |
|
|
2022
Q4 | $10.3M | Buy |
130,700
+4,400
| +3% | +$330K | 0.08% | 224 |
|
|
2022
Q3 | $8.87M | Sell |
126,300
-1,200
| -0.9% | -$94.1K | 0.05% | 256 |
|
|
2022
Q2 | $10.2M | Sell |
127,500
-161,800
| -56% | -$12.7M | 0.05% | 255 |
|
|
2022
Q1 | $21.9M | Sell |
289,300
-287,400
| -50% | -$22.8M | 0.06% | 239 |
|
|
2021
Q4 | $49.2M | Sell |
576,700
-13,400
| -2% | -$1.05M | 0.08% | 204 |
|
|
2021
Q3 | $44.6M | Buy |
590,100
+82,500
| +16% | +$6.55M | 0.09% | 199 |
|
|
2021
Q2 | $41.3M | Sell |
507,600
-45,900
| -8% | -$3.75M | 0.09% | 188 |
|
|
2021
Q1 | $43.6M | Sell |
553,500
-115,900
| -17% | -$9.08M | 0.13% | 158 |
|
|
2020
Q4 | $57.2M | Buy |
669,400
+199,600
| +42% | +$16.5M | 0.19% | 95 |
|
|
2020
Q3 | $36.2M | Buy |
469,800
+107,200
| +30% | +$8.17M | 0.19% | 99 |
|
|
2020
Q2 | $26.6M | Buy |
362,600
+75,300
| +26% | +$5.35M | 0.18% | 102 |
|
|
2020
Q1 | $19.1M | Sell |
287,300
-189,300
| -40% | -$13.4M | 0.31% | 54 |
|
|
2019
Q4 | $32.8M | Buy |
476,600
+75,400
| +19% | +$5.14M | 0.18% | 123 |
|
|
2019
Q3 | $29.5M | Buy |
401,200
+108,600
| +37% | +$7.88M | 0.2% | 105 |
|
|
2019
Q2 | $21M | Buy |
292,600
+120,000
| +70% | +$8.52M | 0.15% | 147 |
|
|
2019
Q1 | $11.8M | Buy |
172,600
+72,400
| +72% | +$4.68M | 0.11% | 185 |
|
|
2018
Q4 | $5.96M | Buy |
100,200
+35,400
| +55% | +$2.21M | 0.07% | 214 |
|
|
2018
Q3 | $4.34M | Buy |
64,800
+51,100
| +373% | +$3.4M | 0.05% | 277 |
|
|
2018
Q2 | $888K | Buy |
+13,700
| New | +$896K | 0.01% | 395 |
|
|
2017
Q1 | – | Sell |
-3,700
| Closed | -$242K | – | 908 |
|
|
2016
Q4 | $242K | Buy |
+3,700
| New | +$254K | 0.01% | 778 |
|
|
2016
Q1 | – | Sell |
-30,000
| Closed | -$2M | – | 659 |
|
|
2015
Q4 | $2M | Sell |
30,000
-56,800
| -65% | -$3.78M | 0.05% | 166 |
|
|
2015
Q3 | $5.51M | Sell |
86,800
-12,200
| -12% | -$797K | 0.13% | 129 |
|
|
2015
Q2 | $6.47M | Sell |
99,000
-52,300
| -35% | -$3.55M | 0.09% | 162 |
|
|
2015
Q1 | $10.5M | Buy |
151,300
+114,000
| +306% | +$7.88M | 0.17% | 108 |
|
|
2014
Q4 | $2.58M | Buy |
+37,300
| New | +$2.52M | 0.04% | 213 |
|
|
2014
Q1 | – | Sell |
-70,000
| Closed | -$4.56M | – | 405 |
|
|
2013
Q4 | $4.56M | Hold |
70,000
| – | – | 0.05% | 215 |
|
|
2013
Q3 | $4.15M | Buy |
+70,000
| New | +$4.15M | 0.04% | 228 |
|
Other funds holding CL
VCM
DAM
VPM
Capstone Investment Advisors's CL Position: Q1 2026 in Review
Capstone Investment Advisors increased its Colgate-Palmolive (CL) stake by 318% in Q1 2026, buying an estimated $11.2M and bringing the position to 165,075 shares worth $14.1M. The position accounts for 0.02% of the portfolio, ranked #236.
Capstone Investment Advisors first reported a position in CL in Q2 2014 and has held it in 32 quarters since. The position peaked at $16.6M in Q4 2014. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Capstone Investment Advisors held 165,075 shares of Colgate-Palmolive worth $14.1M as of Q1 2026.
- Capstone Investment Advisors bought 125,624 Colgate-Palmolive shares in Q1 2026, an estimated $11.2M.
- Colgate-Palmolive made up 0.02% of Capstone Investment Advisors's portfolio in Q1 2026, its #236 holding.
- Capstone Investment Advisors first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 32 quarters since.
- Capstone Investment Advisors's Colgate-Palmolive position peaked at $16.6M in Q4 2014.
- 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.